ECSP003703A - PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents
PHARMACEUTICALLY ACTIVE COMPOUNDSInfo
- Publication number
- ECSP003703A ECSP003703A ECSP003703A ECSP003703A EC SP003703 A ECSP003703 A EC SP003703A EC SP003703 A ECSP003703 A EC SP003703A EC SP003703 A ECSP003703 A EC SP003703A
- Authority
- EC
- Ecuador
- Prior art keywords
- active compounds
- pharmaceutically active
- pharmaceutically
- veterinarily acceptable
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 206010057671 Female sexual dysfunction Diseases 0.000 abstract 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 abstract 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 abstract 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 abstract 1
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 101150098694 PDE5A gene Proteins 0.000 abstract 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 abstract 1
- 229940029575 guanosine Drugs 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los compuestos de la fórmula (I) en la que R1, R2, R4 y R13 son como se han definido, una sal o polimorfo farmacéutica o veterinariamente aceptable de los mismos, o un solvato o profármaco farmacéutica o veterinariamente aceptable de los mismos, son inhibidores potentes y selectivos de la guanosina 3´, 5´-monofosfato cíclico fosfodiesterasa de tipo 5 (GPMc PDE5) y tienen utilidad en el tratamiento de, entre otras afecciones, la disfunción eréctil masculina (MED) y la disfunción sexual femenina (FSD).The compounds of the formula (I) in which R1, R2, R4 and R13 are as defined, a pharmaceutically or veterinarily acceptable salt or polymorph thereof, or a pharmaceutically or veterinarily acceptable solvate or prodrug thereof, are potent and selective guanosine 3´, 5´-cyclic phosphodiesterase type 5 inhibitors (GPMc PDE5) and have utility in the treatment of, among other conditions, male erectile dysfunction (MED) and female sexual dysfunction (FSD) .
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9924632A GB2342959B (en) | 1998-10-19 | 1999-10-18 | A fuel injector |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003703A true ECSP003703A (en) | 2002-05-23 |
Family
ID=40427380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003703 ECSP003703A (en) | 1999-10-18 | 2000-10-10 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003703A (en) |
-
2000
- 2000-10-10 EC ECSP003703 patent/ECSP003703A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23198A3 (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| TR200003039T2 (en) | Pirazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunctions | |
| WO2002064590A3 (en) | Carboline derivatives | |
| MY128479A (en) | (beta)-carboline derivatives useful as inhibitors of phosphodiesterase | |
| WO2002064591A3 (en) | Carboline derivatives | |
| WO2002000657A3 (en) | Condensed pyrazindione derivatives | |
| NO20015275D0 (en) | Unit dosage form | |
| UY28524A1 (en) | TRIAZOL DERIVATIVES REPLACED AS AN OXITOCINE ANTAGONISTS | |
| ATE397606T1 (en) | PYRAZINO(1',2':1,6)-PYRIDO(3,4-B) INDOLE-1,4-DIONE DERIVATIVES | |
| WO2002000656A3 (en) | Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives | |
| PA8534701A1 (en) | DERIVATIVES OF [1, 2, 4] TRIAZOLO [1,5-a] PIRIDINE | |
| GT200200044A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| UY26387A1 (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| HN2000000225A (en) | PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| CA2451990A1 (en) | A new compound for the treatment of impotence | |
| AR030681A1 (en) | PIRAZOLO COMPOUNDS [4,3-] PIRIMIDIN-7-ONAS, PHARMACEUTICAL COMPOSITION, VETERINARY FORMULATION, USE IN THE MANUFACTURE OF MEDICINAL PRODUCT, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS, INTERMEDIARY COMPOUNDS AND THEIR PREPARATION | |
| PA8523501A1 (en) | CRYSTAL THERAPEUTIC AGENT | |
| GB0028245D0 (en) | New therapeutic use | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| DOP2004000999A (en) | TRIAZOL DERIVATIVES REPLACED COO ANTAGONIST OF OXITOCINE |